MedTrace Logo

Treatment Of Chronic Anal Fissure

NCT02158013 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2020-01-14

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of Levorag Emulgel compared with diltiazem gel on the healing of chronic anal fissures.

Conditions

  • Chronic Anal Fissure

Interventions

OTHER

Levorag Emulgel

DRUG

Diltiazem

Sponsors & Collaborators

  • Sacomed

    collaborator OTHER

  • Bispebjerg Hospital

    lead OTHER

Principal Investigators

  • Peter-Martin Krarup, MD · Bispebjerg Hospital

  • Andreas Nordholm-Carstensen, MD · Bispebjerg Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-01
Primary Completion
2018-02-05
Completion
2018-02-05

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02158013 on ClinicalTrials.gov